Syntrillo utilizes an AI-enabled platform that integrates automated disease monitoring, personalized prevention plans, and a remote care team to provide accessible stroke risk management for high-risk patients. The startup addresses the lack of regular neurological care for individuals at risk of stroke, aiming to reduce healthcare costs and improve patient outcomes.
Funding
Funding not disclosed
VVFounders
Product
Problem
Many stroke survivors lack access to regular neurological care after hospital discharge, increasing their risk of recurrent stroke and long-term disability. The rising costs of traditional care and a shortage of neurologists further exacerbate this problem, leaving high-risk patients without adequate preventative measures.
Solution
Syntrillo offers an AI-enabled platform that delivers accessible stroke risk management to high-risk patients through automated disease monitoring, personalized prevention plans, and a remote care team. The platform monitors a patient’s stroke risk and behavior, generating and tracking a personalized prevention plan. An AI virtual assistant provides 24/7 care support to both patients and providers. A remote care team, including neurologists, nurse practitioners, and rehab specialists, ensures high-quality care.
Target Audience
The primary target audience is stroke survivors at high risk of recurrent stroke who lack access to regular neurological care after hospital discharge, with plans to expand to all high-risk patients.
Features
- Automated disease monitoring and management system for stroke risk assessment
- Personalized prevention plan generation and tracking
- AI virtual assistant providing 24/7 care support
- Remote care team access, including neurologists, nurse practitioners, and rehab specialists
- Wearable device integration for biomarker monitoring and high-risk event evaluation
- Clinical software to identify warning signs indicating a high risk of future stroke